Skip to main content
SpringerLink
Log in

Therapy and Rehabilitation of Allergic and Irritant Contact Dermatitis

  • Chapter
  • First Online:
Contact Dermatitis

Abstract

The treatment of and rehabilitation methods in contact dermatitis and the evidence supporting them are presented, following the “rule of the four Rs”: recognize (the causative allergic/irritant agent), remove (the irritant/allergen), reduce inflammation and restore the skin barrier. Avoidance of the inducing allergen(s) and/or irritant(s) is the most important aspect in the management of contact dermatitis and the different measures are reviewed. The principles of basic topical therapy and the treatment modalities – topical corticosteroids, topical cacineurine inhibitors, retinoids, phototherapy, X-ray therapy and systemic corticosteroids and immunosuppressive agents – are described. Their effects on the skin barrier function, as well as those of moisturizers and other factors influencing barrier recovery, are examined separately.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Akhavan A, Cohen SR (2003) The relationship between atopic dermatitis and contact dermatitis. Clin Dermatol 21:158–162

    PubMed  Google Scholar 

  2. Allenby CF, Basketter DA (1993) An arm immersion model of compromised skin (II). Influence on minimal eliciting patch test concentrations of nickel. Contact Derm 28:129–133

    PubMed  CAS  Google Scholar 

  3. Anstey AV, Wakelin S, Reynolds NJ (2004) Guidelines for prescribing azathioprine in dermatology. Br J Dermatol 151:1123–1132

    PubMed  CAS  Google Scholar 

  4. Bagot M, Terki N, Bacha S et al (1999) Per os desensitization in nickel contact eczema: a double-blind placebo-controlled clinico-biological study. Ann Dermatol Venereol 126:502–504

    PubMed  CAS  Google Scholar 

  5. Barany E, Lindberg M, Loden M (2000) Unexpected skin barrier influence from nonionic emulsifiers. Int J Pharm 195:189–195

    PubMed  CAS  Google Scholar 

  6. Basketter DA (2008) Skin sensitization: strategies for the assessment and management of risk. Br J Dermatol 159:267–273

    PubMed  CAS  Google Scholar 

  7. Bayerl C, Gabea A, Peiler D et al (1999) Pilotstudie zur therapie des beruflich bedingten handekzems mit einer neuen tragbaren UVB-bestralungseinheit. Aktuelle Derm 25:302–305

    Google Scholar 

  8. Behrens S, von Kobyletzki G, Gruss C et al (1999) PUVA-bath photochemotherapy (PUVA-soak therapy) of recalcitrant dermatoses of the palms and soles. Photodermatol Photoimmunol Photomed 15:47–51

    PubMed  CAS  Google Scholar 

  9. Belsito DV, Fowler JF Jr, Marks JG Jr et al (2004) Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis. Cutis 73:31–38

    PubMed  Google Scholar 

  10. Berndt U, Hinnen U, Iliev D et al (2000) Hand eczema in metalworker trainees–an analysis of risk factors. Contact Derm 43:327–332

    PubMed  CAS  Google Scholar 

  11. Bissett DL, Hannon DP, Orr TV (1987) An animal model of solar-aged skin: histological, physical, and visible changes in UV-irradiated hairless mouse skin. Photochem Photobiol 46:367–378

    PubMed  CAS  Google Scholar 

  12. Bollag W, Ott F (1999) Successful treatment of chronic hand eczema with oral 9-cis-retinoic acid. Dermatology 199: 308–312

    PubMed  CAS  Google Scholar 

  13. Brand RM, Jendrzejewski JL, Charron AR (2007) Potential mechanisms by which a single drink of alcohol can increase transdermal absorption of topically applied chemicals. Toxicology 235:141–149

    PubMed  CAS  Google Scholar 

  14. Brasch J, Becker D, Aberer W et al (2007) Contact dermatitis. J Dtsch Dermatol Ges 5:943–951

    PubMed  Google Scholar 

  15. Buraczewska I, Loden M (2005) Treatment of surfactant-damaged skin in humans with creams of different pH values. Pharmacology 73:1–7

    PubMed  CAS  Google Scholar 

  16. Buraczewska I, Berne B, Lindberg M et al (2007) Changes in skin barrier function following long-term treatment with moisturizers, a randomized controlled trial. Br J Dermatol 156:492–498

    PubMed  CAS  Google Scholar 

  17. Buraczewska I, Berne B, Lindberg M et al (2009) Moisturizers change the mRNA expression of enzymes synthesizing skin barrier lipids. Arch Dermatol Res 301(8):587–594

    PubMed  CAS  Google Scholar 

  18. CHCP (2009) Assessment report for protopic, p35 London: EMEA. Retrieved 10 July 2009 from http://www.emea.europa.eu/humandocs/PDFs/EPAR/protopic/Protopic-H-C-374-II-34.pdf

    Google Scholar 

  19. Cheng C, Michaels J, Scheinfeld N (2008) Alitretinoin: a comprehensive review. Expert Opin Investig Drugs 17: 437–443

    PubMed  CAS  Google Scholar 

  20. Choi JM, Lee JY, Cho BK (2000) Chronic irritant contact dermatitis: recovery time in man. Contact Derm 42:264–269

    PubMed  CAS  Google Scholar 

  21. De Paepe K, Hachem JP, Vanpee E et al (2001) Beneficial effects of a skin tolerance-tested moisturizing cream on the barrier function in experimentally-elicited irritant and allergic contact dermatitis. Contact Derm 44:337–343

    PubMed  Google Scholar 

  22. Denda M (2002) New strategies to improve skin barrier homeostasis. Adv Drug Deliv Rev 54(suppl 1):S123–S130

    PubMed  CAS  Google Scholar 

  23. Denda M (2009) Methodology to improve epidermal barrier homeostasis: how to accelerate the barrier recovery? Int J Cosmet Sci 31:79–86

    PubMed  CAS  Google Scholar 

  24. Denda M, Tsuchiya T (2000) Barrier recovery rate varies time-dependently in human skin. Br J Dermatol 142:881–884

    PubMed  CAS  Google Scholar 

  25. Diepgen T, Elsner P, Schliemann S et al (2009) Management von handekzemen leitlinie ICD-10-ziffer: L20. L23. L24. L25. L30. J Dtsch Dermatol Ges 7:s1–s16

    PubMed  Google Scholar 

  26. Draelos ZD, Ertel KD, Berge CA (2006) Facilitating facial retinization through barrier improvement. Cutis 78:275–281

    PubMed  Google Scholar 

  27. Egan CA, Rallis TM, Meadows KP et al (1999) Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx. J Am Acad Dermatol 40:612–614

    PubMed  CAS  Google Scholar 

  28. Elias PM (1986) Epidermal effects of retinoids: supramolecular observations and clinical implications. J Am Acad Dermatol 15:797–809

    PubMed  CAS  Google Scholar 

  29. Elias PM (2006) Improving barrier function. In: Elias PM, Feingold KR (eds) Skin barrier. Taylor & Francis, New York

    Google Scholar 

  30. Elias PM (2008) Barrier repair trumps immunology in the pathogenesis and therapy of atopic dermatitis. Drug Discov Today Dis Mech 5:e33–e38

    PubMed  Google Scholar 

  31. Engel K, Reuter J, Seiler C et al (2008) Anti-inflammatory effect of pimecrolimus in the sodium lauryl sulphate test. J Eur Acad Dermatol Venereol 22:447–450

    PubMed  CAS  Google Scholar 

  32. Fairris GM, Jones DH, Mack DP et al (1984) Superficial X-ray therapy in the treatment of constitutional eczema of the feet. Br J Dermatol 111:500–502

    PubMed  CAS  Google Scholar 

  33. Fairris GM, Jones DH, Mack DP et al (1985) Conventional superficial X-ray versus Grenz ray therapy in the treatment of constitutional eczema of the hands. Br J Dermatol 112:339–341

    PubMed  CAS  Google Scholar 

  34. Farage MA, Miller KW, Elsner P et al (2007) Structural characteristics of the aging skin: a review. Cutan Ocul Toxicol 26:343–357

    PubMed  Google Scholar 

  35. Feingold KR (1991) The regulation of epidermal lipid synthesis by permeability barrier requirements. Crit Rev Ther Drug Carrier Syst 8:193–210

    PubMed  CAS  Google Scholar 

  36. Feingold KR (2007) Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res 48:2531–2546

    PubMed  CAS  Google Scholar 

  37. Fluhr JW, Darlenski R, Surber C (2008) Glycerol and the skin: holistic approach to its origin and functions. Br J Dermatol 159:23–34

    PubMed  CAS  Google Scholar 

  38. Fluhr JW, Vienne MP, Lauze C et al (1999) Tolerance profile of retinol, retinaldehyde and retinoic acid under maximized and long-term clinical conditions. Dermatology 199(suppl 1):57–60

    PubMed  CAS  Google Scholar 

  39. Fluhr JW, Kuss O, Diepgen T et al (2001) Testing for irritation with a multifactorial approach: comparison of eight non-invasive measuring techniques on five different irritation types. Br J Dermatol 145:696–703

    PubMed  CAS  Google Scholar 

  40. Folster-Holst R, Latussek E (2007) Synthetic tannins in dermatology–a therapeutic option in a variety of pediatric dermatoses. Pediatr Dermatol 24:296–301

    PubMed  Google Scholar 

  41. Freeman S, Maibach H (1988) Study of irritant contact dermatitis produced by repeat patch test with sodium lauryl sulfate and assessed by visual methods, transepidermal water loss, and laser Doppler velocimetry. J Am Acad Dermatol 19:496–502

    PubMed  CAS  Google Scholar 

  42. Frosch PJ, Schulze-Dirks A (1989) Contact allergy caused by polidocanol. Hautarzt 40:146–149

    Google Scholar 

  43. Gloor M, Senger B, Langenauer M et al (2004) On the course of the irritant reaction after irritation with sodium lauryl sulphate. Skin Res Technol 10:144–148

    PubMed  Google Scholar 

  44. Goh CL (1991) Cutting oil dermatitis on guinea pig skin (I). Cutting oil dermatitis and barrier cream. Contact Derm 24: 16–21

    PubMed  CAS  Google Scholar 

  45. Goldstein AM, Abramovits W (2003) Ceramides and the stratum corneum: structure, function, and new methods to promote repair. Int J Dermatol 42:256–259

    PubMed  CAS  Google Scholar 

  46. Granlund H, Erkko P, Eriksson E et al (1996) Comparison of cyclosporine and topical betamethasone-17, 21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol 76:371–376

    PubMed  CAS  Google Scholar 

  47. Grassberger M, Steinhoff M, Schneider D et al (2004) Pimecrolimus – an anti-inflammatory drug targeting the skin. Exp Dermatol 13:721–730

    PubMed  CAS  Google Scholar 

  48. Grether-Beck S, Muhlberg K, Brenden H et al (2008) Bioactive molecules from the blue lagoon: in vitro and in vivo assessment of silica mud and microalgae extracts for their effects on skin barrier function and prevention of skin ageing. Exp Dermatol 17:771–779

    PubMed  Google Scholar 

  49. Grubauer G, Elias PM, Feingold KR (1989) Transepidermal water loss: the signal for recovery of barrier structure and function. J Lipid Res 30:323–333

    PubMed  CAS  Google Scholar 

  50. Gunathilake R, Schurer NY, Shoo BA et al (2009) PH-regulated mechanisms account for pigment-type differences in epidermal barrier function. J Invest Dermatol 129: 1719–1729

    PubMed  CAS  Google Scholar 

  51. Gupta G, Forsyth A (1999) Allergic contact reactions to colophony presenting as oral disease. Contact Derm 40:332–333

    PubMed  CAS  Google Scholar 

  52. Hachem JP, De Paepe K, Vanpee E et al (2001) Combination therapy improves the recovery of the skin barrier function: an experimental model using a contact allergy patch test combined with TEWL measurements. Dermatology 202: 314–319

    PubMed  CAS  Google Scholar 

  53. Hachem JP, De Paepe K, Vanpee E et al (2002) The effect of two moisturisers on skin barrier damage in allergic contact dermatitis. Eur J Dermatol 12:136–138

    PubMed  Google Scholar 

  54. Hachem JP, Behne M, Aronchik I et al (2005) Extracellular pH controls NHE1 expression in epidermis and keratinocytes: implications for barrier repair. J Invest Dermatol 125:790–797

    PubMed  CAS  Google Scholar 

  55. Handa S, Sahoo B, Sharma VK (2001) Oral hyposensitization in patients with contact dermatitis from Parthenium hysterophorus. Contact Derm 44:279–282

    PubMed  CAS  Google Scholar 

  56. Hanifin JM, Stevens V, Sheth P et al (2004) Novel treatment of chronic severe hand dermatitis with bexarotene gel. Br J Dermatol 150:545–553

    PubMed  CAS  Google Scholar 

  57. Haratake A, Uchida Y, Mimura K et al (1997) Intrinsically aged epidermis displays diminished UVB-induced alterations in barrier function associated with decreased proliferation. J Investig Dermatol 108:319–323

    PubMed  CAS  Google Scholar 

  58. Held E, Sveinsdottir S, Agner T (1999) Effect of long-term use of moisturizer on skin hydration, barrier function and susceptibility to irritants. Acta Derm Venereol 79:49–51

    PubMed  CAS  Google Scholar 

  59. Hindsen M, Bruze M, Christensen OB (1997) The significance of previous allergic contact dermatitis for elicitation of delayed hypersensitivity to nickel. Contact Derm 37:101–106

    PubMed  CAS  Google Scholar 

  60. Holleran WM, Uchida Y, Halkier-Sorensen L et al (1997) Structural and biochemical basis for the UVB-induced alterations in epidermal barrier function. Photodermatol Photoimmunol Photomed 13:117–128

    PubMed  CAS  Google Scholar 

  61. Hölzle E, Gollnick H, Herzinger T et al (2002) Empfehlungen zur Phototherapie und Photochemotherapie, Leitlinien der Deutschen Dermatologischen Gesellschaft (DDG). Düsseldorf. Retrieved 13 July 2009 from http://www.uni-duesseldorf.de/AWMF/ll/013-029.htm

    Google Scholar 

  62. Ingram JR, Batchelor JM, Williams H (2009) Alitretinoin as a potential advance in the management of severe chronic hand eczema. Arch Dermatol 145:314–315

    PubMed  Google Scholar 

  63. Isaksson M (2004) Corticosteroids. Dermatol Ther 17: 314–320

    PubMed  Google Scholar 

  64. Isaksson M, Bruze M (2001) Repetitive usage testing with budesonide in experimental nickel–allergic contact dermatitis in individuals hypersensitive to budesonide. Br J Dermatol 145:38–44

    PubMed  CAS  Google Scholar 

  65. Jacobson MK, Kim H, Coyle WR et al (2007) Effect of myristyl nicotinate on retinoic acid therapy for facial photodamage. Exp Dermatol 16:927–935

    PubMed  CAS  Google Scholar 

  66. Jensen JM, Pfeiffer S, Witt M et al (2009) Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol 123:1124–1133

    PubMed  CAS  Google Scholar 

  67. Jungersted JM, Hellgren LI, Jemec GB et al (2008) Lipids and skin barrier function–a clinical perspective. Contact Derm 58:255–262

    PubMed  CAS  Google Scholar 

  68. Kaaber K, Menne T, Veien NK et al (1987) Some adverse effects of disulfiram in the treatment of nickel-allergic patients. Derm Beruf Umwelt 35:209–211

    PubMed  CAS  Google Scholar 

  69. Kao JS, Fluhr JW, Man MQ et al (2003) Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol 120:456–464

    PubMed  CAS  Google Scholar 

  70. Kim E, Kim S, Nam GW et al (2009) The alkaline pH-adapted skin barrier is disrupted severely by SLS-induced irritation. Int J Cosmet Sci 31(4):263–269

    PubMed  CAS  Google Scholar 

  71. Kolbe L, Kligman AM, Schreiner V et al (2001) Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin. Skin Res Technol 7:73–77

    PubMed  CAS  Google Scholar 

  72. Kowatzki D, Macholdt C, Krull K et al (2008) Effect of regular sauna on epidermal barrier function and stratum corneum water-holding capacity in vivo in humans: a controlled study. Dermatology 217:173–180

    PubMed  CAS  Google Scholar 

  73. Krutmann J, Medve-Koenigs K, Ruzicka T et al (2005) Ultraviolet-free phototherapy. Photodermatol Photoimmunol Photomed 21:59–61

    PubMed  Google Scholar 

  74. Kucharekova M, van De Kerkhof PC, van Der Valk PG (2003) A randomized comparison of an emollient containing skin-related lipids with a petrolatum-based emollient as adjunct in the treatment of chronic hand dermatitis. Contact Derm 48:293–299

    PubMed  CAS  Google Scholar 

  75. Kucharekova M, Hornix M, Ashikaga T et al (200w3) The effect of the PDE-4 inhibitor (cipamfylline) in two human models of irritant contact dermatitis. Arch Dermatol Res 295:29–32

    PubMed  CAS  Google Scholar 

  76. Lee JY, Effendy I, Maibach HI (1997) Acute irritant contact dermatitis: recovery time in man. Contact Derm 36:285–290

    PubMed  CAS  Google Scholar 

  77. Lehmann P, Holzle E, Melnik B et al (1991) Effects of ultraviolet A and B on the skin barrier: a functional, electron microscopic and lipid biochemical study. Photodermatol Photoimmunol Photomed 8:129–134

    PubMed  CAS  Google Scholar 

  78. Levin C, Zhai H, Bashir S et al (2001) Efficacy of corticosteroids in acute experimental irritant contact dermatitis? Skin Res Technol 7:214–218

    PubMed  CAS  Google Scholar 

  79. Lim SH, Kim SM, Lee YW et al (2008) Change of biophysical properties of the skin caused by ultraviolet radiation-induced photodamage in Koreans. Skin Res Technol 14:93–102

    PubMed  CAS  Google Scholar 

  80. Loden M (2005) The clinical benefit of moisturizers. J Eur Acad Dermatol Venereol 19:672–688; quiz 686–687

    Google Scholar 

  81. Löffler H, Aramaki J, Friebe K et al (2002) Changes in skin physiology during bath PUVA therapy. Br J Dermatol 147:105–109

    PubMed  Google Scholar 

  82. Lofgren SM, Warshaw EM (2006) Dyshidrosis: epidemiology, clinical characteristics, and therapy. Dermatitis 17: 165–181

    PubMed  Google Scholar 

  83. Luger T, Paul C (2007) Potential new indications of topical calcineurin inhibitors. Dermatology 215(suppl 1):45–54

    PubMed  CAS  Google Scholar 

  84. Luger T, Elsner P, Kerscher M et al (2009) Topische Dermatotherapie mit Glukokortikoiden – therapeutischer Index. ICD 10: L20. Leitlinien der Deutschen Dermatologischen Gesellschaft (DDG). Düsseldorf. Retrieved 9 July 2009 from http://www.uni-duesseldorf.de/AWMF/ll/013-034.htm

    Google Scholar 

  85. Luger T, Loske KD, Elsner P et al (2004) Topical skin therapy with glucocorticoids – therapeutic index. J Dtsch Dermatol Ges 2:629–634

    PubMed  Google Scholar 

  86. Marcil I, Stern RS (2001) Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study. Lancet 358:1042–1045

    PubMed  CAS  Google Scholar 

  87. Mastrolonardo M, Lopalco PL, Diaferio A (2002) Topical immunotherapy with contact sensitizers: a model to study the natural history of delayed hypersensitivity. Contact Derm 47:210–214

    PubMed  CAS  Google Scholar 

  88. Mauro T, Holleran WM, Grayson S et al (1998) Barrier recovery is impeded at neutral pH, independent of ionic effects: implications for extracellular lipid processing. Arch Dermatol Res 290:215–222

    PubMed  CAS  Google Scholar 

  89. Mrowietz U, Eberhard Klein C, Reich K et al (2000) Therapie mit Ciclosporin in der Dermatologie, Leitlinien der Deutschen Dermatologischen Gesellschaft (DDG). Düsseldorf. Retrieved 15 July 2009 from http://www.uni-duesseldorf.de/AWMF/ll/013-013.htm

    Google Scholar 

  90. Murphy GM, Maurice PD, Norris PG et al (1989) Azathioprine treatment in chronic actinic dermatitis: a double-blind controlled trial with monitoring of exposure to ultraviolet radiation. Br J Dermatol 121:639–646

    PubMed  CAS  Google Scholar 

  91. NICE (2007) Grenz rays therapy for inflammatory skin conditions. Retrieved 03 September 2009 from http://guidance.nice.org.uk/IPG236 and attachments http://guidance.nice.org.uk/IPG236/Guidance/pdf/English and http://www.nice.org.uk/guidance/index.jsp?action=download&o=31797

    Google Scholar 

  92. Nielsen NH, Linneberg A, Menne T et al (2001) Persistence of contact allergy among Danish adults: an 8-year follow-up study. Contact Derm 45:350–353

    PubMed  CAS  Google Scholar 

  93. Nilsson E, Henning C, Hjorleifsson ML (1986) Density of the microflora in hand eczema before and after topical treatment with a potent corticosteroid. J Am Acad Dermatol 15:192–197

    PubMed  CAS  Google Scholar 

  94. Noiesen E, Larsen K, Agner T (2004) Compliance in contact allergy with focus on cosmetic labelling: a qualitative research project. Contact Derm 51:189–195

    PubMed  Google Scholar 

  95. Ong PY (2009) Emerging drugs for atopic dermatitis. Expert Opin Emerg Drugs 14:165–179

    PubMed  CAS  Google Scholar 

  96. Pedersen L, Johansen JD, Held E et al (2004) Augmentation of skin response by exposure to a combination of allergens and irritants – a review. Contact Derm 50:265–273

    PubMed  CAS  Google Scholar 

  97. Petering H, Breuer C, Herbst R et al (2004) Comparison of localized high-dose UVA1 irradiation versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema. J Am Acad Dermatol 50:68–72

    PubMed  Google Scholar 

  98. Pickenacker A, Luger TA, Schwarz T (1998) Dyshidrotic eczema treated with mycophenolate mofetil. Arch Dermatol 134:378–379

    PubMed  CAS  Google Scholar 

  99. Polderman MC, Govaert JC, le Cessie S et al (2003) A double-blind placebo-controlled trial of UVA-1 in the treatment of dyshidrotic eczema. Clin Exp Dermatol 28:584–587

    PubMed  CAS  Google Scholar 

  100. Proksch E, Brandner JM, Jensen JM (2008) The skin: an indispensable barrier. Exp Dermatol 17:1063–1072

    PubMed  Google Scholar 

  101. Proksch E, Nissen HP, Bremgartner M et al (2005) Bathing in a magnesium-rich dead sea salt solution improves skin barrier function, enhances skin hydration, and reduces inflammation in atopic dry skin. Int J Dermatol 44:151–157

    PubMed  Google Scholar 

  102. Queille-Roussel C, Graeber M, Thurston M et al (2000) SDZ ASM 981 is the first non-steroid that suppresses established nickel contact dermatitis elicited by allergen challenge. Contact Derm 42:349–350

    PubMed  CAS  Google Scholar 

  103. Ramsing DW, Agner T (1995) Efficacy of topical corticosteroids on irritant skin reactions. Contact Derm 32:293–297

    PubMed  CAS  Google Scholar 

  104. Ramsing DW, Agner T (1997) Preventive and therapeutic effects of a moisturizer. An experimental study of human skin. Acta Derm Venereol 77:335–337

    PubMed  CAS  Google Scholar 

  105. Reitamo S, Granlund H (1994) Cyclosporin A in the treatment of chronic dermatitis of the hands. Br J Dermatol 130: 75–78

    PubMed  CAS  Google Scholar 

  106. Reymann F (1982) Two years’ experience with tigason treatment of pustulosis palmo-plantaris and eczema keratoticum manuum. Dermatologica 164:209–216

    PubMed  CAS  Google Scholar 

  107. Ring J, Barker J, Behrendt H et al (2005) Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European dermatology forum. J Eur Acad Dermatol Venereol 19:663–671

    PubMed  CAS  Google Scholar 

  108. Robles TF (2007) Stress, social support, and delayed skin barrier recovery. Psychosom Med 69:807–815

    PubMed  Google Scholar 

  109. Rogers J, Harding C, Mayo A et al (1996) Stratum corneum lipids: the effect of ageing and the seasons. Arch Dermatol Res 288:765–770

    PubMed  CAS  Google Scholar 

  110. Ruzicka T, Lynde CW, Jemec GB et al (2008) Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 158:808–817

    PubMed  CAS  Google Scholar 

  111. Sajjachareonpong P, Cahill J, Keegel T et al (2004) Persistent post-occupational dermatitis. Contact Derm 51:278–283

    PubMed  Google Scholar 

  112. Schempp CM, Muller H, Czech W et al (1997) Treatment of chronic palmoplantar eczema with local bath-PUVA therapy. J Am Acad Dermatol 36:733–737

    PubMed  CAS  Google Scholar 

  113. Schliemann S, Kelterer D, Bauer A et al (2008) Tacrolimus ointment in the treatment of occupationally induced chronic hand dermatitis. Contact Derm 58:299–306

    PubMed  CAS  Google Scholar 

  114. Schmidt T, Abeck D, Boeck K et al (1998) UVA1 irradiation is effective in treatment of chronic vesicular dyshidrotic hand eczema. Acta Derm Venereol 78:318–319

    PubMed  CAS  Google Scholar 

  115. Schmitt J, Schmitt N, Meurer M (2007) Cyclosporin in the treatment of patients with atopic eczema – a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 21:606–619

    PubMed  CAS  Google Scholar 

  116. Schoepe S, Schacke H, May E et al (2006) Glucocorticoid therapy-induced skin atrophy. Exp Dermatol 15:406–420

    PubMed  CAS  Google Scholar 

  117. Shaffrali FC, Colver GB, Messenger AG et al (2003) Experience with low-dose methotrexate for the treatment of eczema in the elderly. J Am Acad Dermatol 48:417–419

    PubMed  Google Scholar 

  118. Sharma AD (2007) Relationship between nickel allergy and diet. Indian J Dermatol Venereol Leprol 73:307–312

    PubMed  Google Scholar 

  119. Skudlik C, Weisshaar E, Scheidt R et al (2009) Multicenter study “Medical-occupational rehabilitation procedure skin – optimizing and quality assurance of inpatient-management (ROQ)”. J Dtsch Dermatol Ges 7:122–126

    PubMed  Google Scholar 

  120. Stege H (2008) Ultraviolet therapy in patients with chronic hand eczema. Hautarzt 59:696–702

    PubMed  CAS  Google Scholar 

  121. Stucker M, Hoffmann M, Altmeyer P (2002) Instrumental evaluation of retinoid-induced skin irritation. Skin Res Technol 8:133–140

    PubMed  CAS  Google Scholar 

  122. Tagami H, Tadaki T, Obata M et al (1992) Functional assessment of the stratum corneum under the influence of oral aromatic retinoid (etretinate) in guinea-pigs and humans. Comparison with topical retinoic acid treatment. Br J Dermatol 127:470–475

    PubMed  CAS  Google Scholar 

  123. Thelmo MC, Lang W, Brooke E et al (2003) An open-label pilot study to evaluate the safety and efficacy of topically applied tacrolimus ointment for the treatment of hand and/or foot eczema. J Dermatolog Treat 14:136–140

    PubMed  CAS  Google Scholar 

  124. Thestrup-Pedersen K, Andersen KE, Menne T et al (2001) Treatment of hyperkeratotic dermatitis of the palms (eczema keratoticum) with oral acitretin. A single-blind placebo-controlled study. Acta Derm Venereol 81:353–355

    PubMed  CAS  Google Scholar 

  125. Tsutsumi M, Denda M (2007) Paradoxical effects of beta-estradiol on epidermal permeability barrier homeostasis. Br J Dermatol 157:776–779

    PubMed  CAS  Google Scholar 

  126. Uter W, Geier J, Fuchs T (2000) Contact allergy to polidocanol, 1992 to 1999. J Allergy Clin Immunol 106: 1203–1204

    PubMed  CAS  Google Scholar 

  127. Uter W, de Padua CM, Pfahlberg A et al (2009) Contact allergy to topical corticosteroids–results from the IVDK and epidemiological risk assessment. J Dtsch Dermatol Ges 7(34–41):34–42

    PubMed  Google Scholar 

  128. Vakeva L, Reitamo S, Pukkala E et al (2008) Long-term follow-up of cancer risk in patients treated with short-term cyclosporine. Acta Derm Venereol 88:117–120

    PubMed  CAS  Google Scholar 

  129. van Coevorden AM, Kamphof WG, van Sonderen E et al (2004) Comparison of oral psoralen-UV-A with a portable tanning unit at home vs hospital-administered bath psoralen-UV-A in patients with chronic hand eczema: an open-label randomized controlled trial of efficacy. Arch Dermatol 140:1463–1466

    PubMed  Google Scholar 

  130. van Coevorden AM, Coenraads PJ, Svensson A et al (2004) Overview of studies of treatments for hand eczema-the EDEN hand eczema survey. Br J Dermatol 151:446–451

    PubMed  Google Scholar 

  131. van der Valk PG, Maibach HI (1989) Do topical corticosteroids modulate skin irritation in human beings? Assessment by transepidermal water loss and visual scoring. J Am Acad Dermatol 21:519–522

    PubMed  Google Scholar 

  132. Veenhuis RT, van Horssen J, Bos RP et al (2002) Highly increased urinary 1-hydroxypyrene excretion rate in patients with atopic dermatitis treated with topical coal tar. Arch Dermatol Res 294:168–171

    PubMed  CAS  Google Scholar 

  133. Veien NK, Olholm Larsen P, Thestrup-Pedersen K et al (1999) Long-term, intermittent treatment of chronic hand eczema with mometasone furoate. Br J Dermatol 140: 882–886

    PubMed  CAS  Google Scholar 

  134. Verma KK, Bansal A, Sethuraman G (2006) Parthenium dermatitis treated with azathioprine weekly pulse doses. Indian J Dermatol Venereol Leprol 72:24–27

    PubMed  Google Scholar 

  135. Verma KK, Mahesh R, Srivastava P et al (2008) Azathioprine versus betamethasone for the treatment of parthenium dermatitis: a randomized controlled study. Indian J Dermatol Venereol Leprol 74:453–457

    PubMed  Google Scholar 

  136. Wall LM, Gebauer KA (1991) A follow-up study of occupational skin disease in Western Australia. Contact Derm 24:241–243

    PubMed  CAS  Google Scholar 

  137. Warner JA, Cruz PD Jr (2008) Grenz ray therapy in the new millennium: still a valid treatment option? Dermatitis 19: 73–80

    PubMed  Google Scholar 

  138. Watkins SA, Maibach H (2009) The hardening phenomenon in irritant contact dermatitis: an interpretative update. Contact Derm 60:123–130

    PubMed  Google Scholar 

  139. Watson AL, Fray TR, Bailey J et al (2006) Dietary constituents are able to play a beneficial role in canine epidermal barrier function. Exp Dermatol 15:74–81

    PubMed  CAS  Google Scholar 

  140. Watson ES (1986) Toxicodendron hyposensitization programs. Clin Dermatol 4:160–170

    PubMed  CAS  Google Scholar 

  141. Widmer J, Elsner P, Burg G (1994) Skin irritant reactivity following experimental cumulative irritant contact dermatitis. Contact Derm 30:35–39

    PubMed  CAS  Google Scholar 

  142. Wilhelm K-P, Freitag G, Wolff HH (1994) Surfactant-induced skin irritation and skin repair: evaluation of a cumulative human irritation model by noninvasive techniques. J Am Acad Dermatol 31:981–987

    PubMed  CAS  Google Scholar 

  143. Wilkinson SM, Cartwright PH, English JS (1991) Hydrocortisone: an important cutaneous allergen. Lancet 337:761–762

    PubMed  CAS  Google Scholar 

  144. Williams S, Krueger N, Davids M et al (2007) Effect of fluid intake on skin physiology: distinct differences between drinking mineral water and tap water. Int J Cosmet Sci 29:131–138

    PubMed  CAS  Google Scholar 

  145. Wise M, Callen JP (2007) Azathioprine: a guide for the management of dermatology patients. Dermatol Ther 20: 206–215

    PubMed  Google Scholar 

  146. Wollina U (2008) Pompholyx: what’s new? Expert Opin Investig Drugs 17:897–904

    PubMed  CAS  Google Scholar 

  147. Zachariae C, Held E, Johansen JD et al (2003) Effect of a moisturizer on skin susceptibility to NiCl2. Acta Derm Venereol 83:93–97

    PubMed  CAS  Google Scholar 

  148. Zhai H, Maibach HI (2002) Occlusion vs. skin barrier function. Skin Res Technol 8:1–6

    PubMed  Google Scholar 

  149. Zhai H, Chang YC, Singh M et al (1999) In vivo nickel allergic contact dermatitis: human model for topical therapeutics. Contact Derm 40:205–208

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Friedrich Schiller University, Erfurter Straße 35, 07743, Jena, Germany

    Dimitar Antonov, Sibylle Schliemann & Peter Elsner

Authors
  1. Dimitar Antonov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sibylle Schliemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter Elsner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter Elsner .

Editor information

Editors and Affiliations

  1. Dept. Dermatology, Amtssygehuset Gentofte, Niels Andersens Vej 65, Hellerup, 2900, Denmark

    Jeanne Duus Johansen

  2. Klinikzentrum Mitte, Hautklinik, Städtische Kliniken Dortmund, Beurhausstr. 40, Dortmund, 44137, Germany

    Peter J. Frosch

  3. Labo. Dermatochimie, Institut le Bel, rue Blaise Pascal 4, Strasbourg CX, 67070, France

    Jean-Pierre Lepoittevin

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Antonov, D., Schliemann, S., Elsner, P. (2011). Therapy and Rehabilitation of Allergic and Irritant Contact Dermatitis. In: Johansen, J., Frosch, P., Lepoittevin, JP. (eds) Contact Dermatitis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-03827-3_49

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-03827-3_49

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-03826-6

  • Online ISBN: 978-3-642-03827-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation